Yes very exciting times, those videos I posted were just uploaded by the company 5 days ago, most of the interested parties tuned into them during the live stream seminars. You are correct heart failure is a much larger market, from memory I think the company expected for every 3 devices sold for lymphedema there would be 10 devices sold for heart failure.
Once BIS is included in the national guidelines i would expect a dual listing on the US stock exchange not long after since 95% of our sales are in the US, my personal opinion anyway.
It amazes me we only have a 89 million dollar market cap considering our future potential, but as I always say common sense will prevail one day.
